Trials / Withdrawn
WithdrawnNCT02509182
The Effect of Decreasing the Inspired Oxygen Concentration on Post-Operative Oxygenation After Primary Lobectomy
The Effect of Decreasing the Inspired Oxygen Concentration on Post-Operative Oxygenation After Primary Lobectomy: A Randomized Controlled Trial
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the hypothesis that decreasing the inspired oxygen concentration during thoracic surgery requiring one lung ventilation will improve post-operative oxygenation.
Detailed description
One lung ventilation is frequently required during thoracic surgery and results in decreased lung function post-operatively. Supra-physiologic oxygen levels during surgery may contribute to this decrease in lung function by worsening lung injury intra-operatively. This study will include patients undergoing surgery to remove a lung lobe requiring one lung ventilation. The patients will be divided into two groups with the experimental group receiving a 60% oxygen in air mixture and the control group receiving 100% oxygen. The two groups will be compared by using a measure of lung function (the ratio of the partial pressure of oxygen in arterial blood to the inspired oxygen concentration) and blood levels of a protein correlated with lung injury (receptor of advanced glycation end products RAGE).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 60% oxygen | An inspired oxygen concentration of 60% will be administered during pulmonary lobectomy surgery. |
| DRUG | 100% oxygen | An inspired oxygen concentration of 100% will be administered during pulmonary lobectomy surgery. |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-07-01
- Completion
- 2018-07-01
- First posted
- 2015-07-27
- Last updated
- 2018-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02509182. Inclusion in this directory is not an endorsement.